News
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...
For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...
Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...
Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...
The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...
As the nearly 130-year-old pharmaceutical company consolidated its CRM systems, it cut down on vendor costs and paved the way ...
April 22 (UPI) -- Biotechnology giant Roche said it will invest $50 billion into the United States over the next five years.
Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active ...
The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...
Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...
Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...
Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results